JFS Wealth Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $114K | Sell |
1,060
-35
| -3% | -$3.76K | 0.01% | 356 |
|
|
2025
Q1 | $110K | Buy |
1,095
+11
| +1% | +$1.11K | 0.01% | 360 |
|
|
2024
Q4 | $96.8K | Buy |
1,084
+1
| +0.1% | +$89 | 0.01% | 365 |
|
|
2024
Q3 | $90.8K | Buy |
1,083
+6
| +0.6% | +$503 | 0.01% | 378 |
|
|
2024
Q2 | $82.9K | Sell |
1,077
-191
| -15% | -$14.7K | 0.01% | 347 |
|
|
2024
Q1 | $86.8K | Buy |
1,268
+185
| +17% | +$12.7K | 0.01% | 341 |
|
|
2023
Q4 | $62.6K | Buy |
1,083
+49
| +5% | +$2.83K | 0.01% | 374 |
|
|
2023
Q3 | $54.6K | Hold |
1,034
| – | – | 0.01% | 367 |
|
|
2023
Q2 | $55.9K | Sell |
1,034
-11
| -1% | -$595 | 0.01% | 360 |
|
|
2023
Q1 | $52.3K | Buy |
1,045
+4
| +0.4% | +$200 | ﹤0.01% | 369 |
|
|
2022
Q4 | $48.2K | Buy |
1,041
+8
| +0.8% | +$370 | ﹤0.01% | 368 |
|
|
2022
Q3 | $40K | Buy |
1,033
+120
| +13% | +$4.65K | ﹤0.01% | 422 |
|
|
2022
Q2 | $34K | Sell |
913
-81
| -8% | -$3.02K | ﹤0.01% | 471 |
|
|
2022
Q1 | $44K | Buy |
994
+302
| +44% | +$13.4K | ﹤0.01% | 448 |
|
|
2021
Q4 | $29K | Sell |
692
-47
| -6% | -$1.97K | ﹤0.01% | 506 |
|
|
2021
Q3 | $32K | Buy |
739
+694
| +1,542% | +$30.1K | ﹤0.01% | 472 |
|
|
2021
Q2 | $2K | Hold |
45
| – | – | ﹤0.01% | 545 |
|
|
2021
Q1 | $2K | Sell |
45
-143
| -76% | -$6.36K | ﹤0.01% | 537 |
|
|
2020
Q4 | $7K | Buy |
188
+143
| +318% | +$5.32K | ﹤0.01% | 438 |
|
|
2020
Q3 | $2K | Hold |
45
| – | – | ﹤0.01% | 501 |
|
|
2020
Q2 | $2K | Hold |
45
| – | – | ﹤0.01% | 477 |
|
|
2020
Q1 | $1K | Sell |
45
-45
| -50% | -$1K | ﹤0.01% | 464 |
|
|
2019
Q4 | $4K | Hold |
90
| – | – | ﹤0.01% | 415 |
|
|
2019
Q3 | $4K | Buy |
+90
| New | +$4K | ﹤0.01% | 413 |
|